Regeneron and Mammoth announce gene editing partnership worth $370m per target
The companies will aim to develop CRISPR-based therapies for multiple tissues and cell types
The companies will aim to develop CRISPR-based therapies for multiple tissues and cell types
The companies will aim to develop CRISPR-based therapies for multiple tissues and cell types
The deal includes an MRGPRX2 antagonist with the potential to treat multiple mast cell-mediated diseases
Under the brand name Tevimbra, the company will combine the NSCLC indications with the second-line ESCC indication in late 2024
The rare neurotrophic virus is responsible for an estimated 59,000 global deaths every year
Healthcare agencies can submit their entries free of charge with a deadline of 30 April
Apr 23, 2024 | Thought Leadership
By Jake Crute
Read MoreApr 22, 2024 | Thought Leadership
By Phil Streit
Read MoreApr 17, 2024 | Appointments
Dunford recently served as executive creative director at TBWA\WorldHealth
Read MoreApr 5, 2024 | Appointments
Colucci previously served as chief executive officer and chairman of Publicis Health
Read MoreApr 25, 2024 | Intelligence
With 14 million people in Europe expected to suffer from Alzheimer’s and other forms of dementia by 2030, the race is on to find a treatment to not only slow its course, but even prevent the development of the disease
Read MoreApr 24, 2024 | Intelligence
PME speaks to Lorna Pender, Global Patient Engagement Lead at Clinigen, about the treatment options available to patients with rare diseases and the barriers that are hindering access
Read MoreApr 19, 2024 | Intelligence
Industry is urged to ditch the simple slogans and instead embrace the complexity, as delving more deeply could improve success rates
Read MoreApr 18, 2024 | Intelligence
PME spoke to Marci English, Vice President and Head of BioPharma Development, Astellas, about the importance of new treatments for menopause symptoms, the unmet need and the company’s commitment to midlife women’s health
Read MoreApr 10, 2024 | Intelligence
Expert strategists ask four crucial questions – the first one confounds most of us
Read MoreApr 8, 2024 | Intelligence
PME spoke to Remi Turbet Delof from Systech about his work with customers to help them navigate the complex world of serialisation
Read MoreApril 24, 2024 | Medscape Education Global|CME, MedEd, Nursing, ONS2024, ONSCongress, medicaleducation, oncology
The Medscape Oncology team will be connecting with the oncology nursing community this week in Washington, DC for the ONS Congress 2024. Medscape Oncology has …
April 24, 2024 | Medscape Education Global|Precision Education, impact, medical education, outcomes, transformation
The CME industry is changing. More than ever, activities need to be prioritized and measured to increase their impact on patient outcomes. Improving patient outcomes …
April 24, 2024 | LOVELIVE|
Cheshire creative agency LOVELIVE has unveiled a new-look branding; coinciding with the launch of a new website as they celebrate 22% year on year growth …
April 24, 2024 | Fox&Cat|Efficient and effective, High value, People-first, Senior consultant network, healthcare communications
F&C network team picture, March 2024 Fox&Cat relaunches today with its new people-first, senior consultant operating model and bespoke planning framework, ADAPTTM. The agency’s lean …
April 17, 2024 | Research Partnership|
Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.
April 24, 2024 | Research Partnership|Syndicated, market research, oncology, therapy watch
This Acute Myeloid Leukemia infographic offers a snapshot of the real-world patient insights collected by our Therapy Watch study, based on data collected from a …
April 22, 2024 | Research Partnership|
Authored by: Ellie Forde and Mark Braund, Directors
April 17, 2024 | Mednet Group|Stress Awareness Month
Explore how we’re supporting our team with managing stress in the workplace
April 11, 2024 | Research Partnership|
The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective …
April 9, 2024 | Mtech Access|
The Institute for Clinical and Economic Review (ICER) is becoming an increasingly important player in US market access. As more transformative, but costly, treatments come …
Account Specialist - Respiratory - Kent & Medway
Marketing Manager - Aesthetics - Hertfordshire
Account Manager - Nutrition - Herts/Northants/Bucks/W Essex
Primary Care Immunisation Facilitator - North West England